Syneos Health Inc. Shareholder Investigation Submission Form
Levi & Korsinsky, LLP has commenced an investigation into the fairness of the acquisition of SYNH. As a result of the merger, SYNH stockholders are anticipated to receive only $43.00 per share in cash, well below the 52-week high of $79.77 per share. The SYNH merger investigation concerns whether the Board of SYNH has harmed stockholders by agreeing to enter into the transaction with a consortium of private investment firm affiliates composed of Elliott Investment Management, Patient Square Capital, and Veritas Capital, and whether all material facts have been properly disclosed to stockholders.
To receive more information, please fill out the form.